|
|
|
|
|
|
|
|
|
|
NCCS clinicians harness MRI to tailor brachytherapy radiation dose to tumour |
|
|
| Brachytherapy
: 09 August, 2012 |
|
The ability of MRI to create images of the body's soft tissues - and the tumours that arise amid them - is helping physicians at National Cancer Centre Singapore (NCCS) to precisely shape brachytherapy doses to cervical tumours, while at the same time avoiding exposure to critical healthy organs and tissues. |
| |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Nucletron receives 510(k) clearance for precise VCMC applicator |
|
|
| Brachytherapy
: 04 October, 2011 |
|
Nucletron, an Elekta company, receives FDA 510(k) clearance for the company's new Vaginal CT/MR Multi Channel (VCMC) Applicator which offers a brachytherapy solution that enables precise dose delivery for gynaecologic cancers.
|
| |
|
|
|
 |
|
|
|
Elekta acquires Nucletron |
|
|
| Brachytherapy
: 19 September, 2011 |
|
Elekta completes its acquisition of Nucletron, the world leader in brachytherapy treatment planning and delivery. |
| |
|
|
|
 |
|
|
|
World's first Cesium-131 treatment for gynaecological cancer is completed |
|
|
| Brachytherapy
: 16 August, 2011 |
|
A newn milestone in the use of IsoRay's proprietary Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) is achieved with the University of Kentucky's Radiation Oncologist Dr Marcus Randall performing the world's first Cesium-131 brachytherapy seed implant for gynaecological cancer on a female patient whose cancer had reoccurred following previous radiation treatment. |
| |
|
|
|
 |
|
|
|
|
|
|
|
|
|
Istituto Europeo di Oncologia treats breast cancer with precise brachytherapy tool |
|
|
| Brachytherapy
: 08 March, 2010 |
|
The Istituto Europeo di Oncologia is the first hospital in Europe to treat breast cancer using a revolutionary system called AccuBoost, which was certified for use in Europe just six weeks ago and was developed by Nucletron and ART, two companies specialising in advancing radiation oncology by developing state-of-the-art equipment for high precision brachytherapy. |
| |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
NeoVista prepares to distribute Wet AMD Device in Europe |
|
|
| Brachytherapy
: 02 April, 2008 |
|
NeoVista has received approval from BSI Product Services to apply the CE Marking to the company's focal epiretinal brachytherapy device, utilised in a new treatment for wet age-related macular degeneration (AMD). |
| |
|
|
|
 |
|
|
|
NeoVista’s novel wet AMD therapy reports study finding |
|
|
| Brachytherapy
: 31 March, 2008 |
|
NeoVista has released updated results from a one-year feasibility study of the company's novel epiretinal brachytherapy for the wet form of age-related macular degeneration (AMD) at the 31st Annual Macula Society Meeting in Palm Beach, Florida, USA |
| |
|
|
|
 |
|
|
|
|
|
|
|
|
|